General Announcement::Announcement

Issuer & Securities

Issuer/ Manager
JUBILANT PHARMA LIMITED
Securities
JUBILANTP US$200M6%N240305 - XS1958658509 - KBSB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
19-Apr-2021 17:00:14
Status
New
Announcement Sub Title
Announcement
Announcement Reference
SG210419OTHR1V3J
Submitted By (Co./ Ind. Name)
Shyam S. Bhartia
Designation
Chairman and Managing Director
Effective Date and Time of the event
19/04/2021 17:00:00
Description (Please provide a detailed description of the event in the box below)
We enclose a communication pertaining to development of a novel oral formulation of Remdesivir with successful completion of safety and pharmacokinetic/absorption studies.

Attachments

JPL_SGX_Disclosure_April_19_2021.pdf
Total size =529K